Information Sheet: Breast Self-Awareness

Updated 2025 — Y-ME National Breast Cancer Organization

Overview

Y-ME National Breast Cancer Organization supports the shift in terminology — and in concept — from Breast Self-Examination (BSE) to Breast Self-Awareness (BSA). This distinction, endorsed by leading institutions including MD Anderson Cancer Center and the American Cancer Society, reflects an important evolution in how we think about breast health.

Breast self-awareness is not a formalized, step-by-step monthly examination performed on a schedule. It is something broader and more sustainable: a woman’s ongoing familiarity with how her breasts normally look and feel — so that she can recognize when something changes and report it promptly to her health care provider.

This distinction matters because the evidence base for formal, structured BSE — performed in a specific technique on a fixed schedule — has not demonstrated a clear survival benefit. However, the evidence strongly supports breast self-awareness as a component of overall breast health, and the majority of breast cancers that are found by women are discovered incidentally through everyday familiarity, not through formal examination technique.

What the Research Shows

The scientific evidence on formal BSE has been debated for decades, and the conclusions remain nuanced:

• The landmark Shanghai Randomized Controlled Trial (Thomas et al., 2002, Journal of the National Cancer Institute) — the largest and most rigorously designed BSE trial ever conducted — followed over 260,000 women for more than a decade. It found no statistically significant difference in breast cancer mortality between women who received intensive BSE instruction and those who did not. However, women in the BSE group did undergo significantly more biopsies for benign findings, raising questions about potential harm from overdiagnosis and unnecessary procedures.
• The Russian cohort study (Semiglazov et al., 2004), presented at the European Breast Cancer Conference, similarly found no survival advantage from intensive BSE training over a control group.
• A Cochrane systematic review of two large randomized controlled trials (Kösters & Gøtzsche, 2003, updated 2008) concluded that there was no evidence that BSE screening reduces breast cancer mortality, and noted the risk of increased false-positive findings leading to unnecessary biopsies.
• Despite the lack of survival evidence for formal BSE, studies consistently show that women who are familiar with their own bodies detect interval cancers — cancers arising between scheduled screenings — and that tumors found by women themselves are often reported more promptly when those women have a clear baseline sense of what is normal for them.
• Current evidence supports that breast self-awareness, combined with regular clinical breast exams and age-appropriate mammography screening, forms part of a comprehensive breast health strategy. No single tool is sufficient alone.

What Leading Organizations Currently Recommend

Y-ME Position

Y-ME National Breast Cancer Organization does not believe that existing research results are strong enough to either definitively support or dismiss the value of formal breast self-examination as a standalone screening tool. The evidence clearly does not support BSE as a mortality-reducing screening intervention in the same way mammography does.

However, Y-ME strongly believes in the value of breast self-awareness — and there is an important difference between the two concepts.

Our position is as follows:

• Every woman should be familiar with her own breasts — their normal texture, appearance, and how they change across the menstrual cycle. This baseline familiarity is what makes it possible to notice something new.
• Formal monthly BSE is a personal choice. Women who choose to perform regular, structured self-exams should receive proper instruction from a health care provider and should not be made to feel that one particular technique is mandatory.
• Women who choose not to perform formal BSE should never be made to feel guilty. The goal is awareness, not anxiety.
• Any new or unusual change should be reported to a health care provider promptly, regardless of how or when it was discovered — during a formal exam, incidentally in the shower, or at any other time.
• Breast self-awareness is a complement to — not a substitute for — regular clinical breast exams and age-appropriate screening mammography.
• Y-ME strongly supports continued research into better diagnostic and early detection tools for breast cancer across all ages and risk groups.

Signs and Changes to Report to Your Doctor

Whether or not you perform formal monthly BSE, you should contact your health care provider if you notice any of the following:

• A new lump, thickening, or hard area in the breast or underarm
• A change in the size, shape, or contour of either breast
• Skin changes — dimpling, puckering, redness, scaliness, or a texture resembling an orange peel (peau d’orange)
• A change in the nipple — inversion, retraction, or a change in direction
• Nipple discharge — particularly if bloody, from one breast only, or spontaneous (not produced by squeezing)
• Persistent pain or tenderness localized to one area that does not resolve with your cycle
• Visible veins or warmth in one breast that were not previously present

Finding something unusual does not mean you have cancer. Approximately 80% of breast lumps turn out to be benign — including cysts (fluid-filled sacs) and fibroadenomas (benign solid tumors). But any new finding deserves prompt evaluation.

Frequently Asked Questions

Will doing BSE save my life?

Current scientific evidence from randomized controlled trials does not demonstrate that formal BSE reduces breast cancer mortality. However, being familiar with your body — breast self-awareness — does matter. Women who know what is normal for them are better positioned to notice changes early and seek evaluation promptly, which can influence outcomes.

Why practice breast self-awareness at all?

Because the majority of breast changes noticed by women are found incidentally — not through a formal monthly exam performed by the book, but through everyday body familiarity. Knowing your own normal is one of the simplest and most powerful things you can do for your breast health. It costs nothing and has no downside when practiced without anxiety or obsession.

Does BSE help find cancer earlier?

Screening mammography remains the most effective tool for detecting breast cancer before symptoms develop. However, interval cancers — those arising between scheduled mammograms — can sometimes be felt before they appear on imaging. Being familiar with your breasts increases the likelihood that you will notice and report a change promptly, which supports earlier evaluation.

How often should I examine my breasts?

There is no single required frequency. For those who choose formal BSE, once a month is the traditional recommendation — ideally 7 to 10 days after the start of your period, when breast tissue is least tender. If you no longer menstruate, choose a consistent date each month. For breast self-awareness more broadly, simply remaining attuned to your body throughout daily life is sufficient.

When should I start?

Breast self-awareness is appropriate at any age. The American Cancer Society suggests that women in their 20s can begin performing optional BSE and should receive counseling about breast changes at routine health visits. Women at higher-than-average risk (due to family history, genetic mutations, or prior chest radiation) should discuss earlier and more intensive screening strategies with their doctor.

Is there a right way to do BSE?

There is no single mandated technique. The most commonly taught method uses the pads of three fingers in overlapping circular motions, following a vertical strip pattern across the entire breast and underarm area, applying light, medium, and firm pressure at each point. However, the method matters less than consistency, thoroughness, and knowing what is normal for you. Ask your health care provider to demonstrate a technique and guide you on what to look and feel for.

What if I choose not to do BSE?

That is entirely your right. You should never feel pressured or guilty for not performing formal BSE. What matters most is that you remain generally aware of your breast health, attend recommended screenings, and report any changes to your doctor without delay.

Are all lumps cancerous?

No. Approximately 80% of breast lumps are benign. Common benign causes include simple cysts (fluid-filled sacs), fibroadenomas (firm, smooth, movable benign tumors), and fibrocystic changes — all of which are non-cancerous. However, any new or changing lump deserves evaluation by a health care provider. Do not try to self-diagnose.

Why is there still controversy around BSE?

Because the randomized trial evidence does not show a mortality benefit from formal BSE, and conducting the large-scale, long-term trials needed to definitively resolve the question is logistically and financially challenging. The ongoing debate reflects genuine scientific uncertainty — not a lack of concern for women’s health. Most major organizations have responded by shifting the focus from formal examination technique to breast self-awareness, which sidesteps some of the controversy while preserving the core message: know your body, notice changes, and speak up.

References

Kösters, J. P., & Gøtzsche, P. C. (2003, updated 2008). Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database of Systematic Reviews, 2, CD003373.

Semiglazov, V. F., Mikhailov, E. A., Manikhas, A. G., et al. (2004). Abstract 109 presented at the 4th European Breast Cancer Conference, Hamburg, Germany. European Journal of Cancer Supplement, 2(3), 87.

Thomas, D. B., Gao, D. L., Ray, R. M., et al. (2002). Randomized trial of breast self-examination in Shanghai: Final results. Journal of the National Cancer Institute, 94(19), 1445–1457.

American Cancer Society. (2024). Breast cancer early detection and diagnosis. cancer.org

American College of Obstetricians and Gynecologists. (2023). Breast cancer risk assessment and screening in average-risk women. Practice Bulletin No. 179 (Reaffirmed 2023). ACOG.

National Comprehensive Cancer Network. (2024). NCCN Clinical Practice Guidelines in Oncology: Breast Cancer Screening and Diagnosis. Version 1.2024. NCCN.

U.S. Preventive Services Task Force. (2024). Breast cancer screening: Recommendation statement. JAMA.

This information sheet is intended for educational purposes and does not constitute medical advice. Always consult a qualified health care provider regarding your individual breast health needs and screening plan.

For peer support or breast cancer information, contact the Y-ME National Breast Cancer Organization Hotline at 1-800-221-2141, available 24 hours a day, 7 days a week. Spanish language support: 1-800-986-9505.